Skip to Main Content

Paper Details

Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study.
J Clin Oncol
91
2002
MYCN, PATIENTS, Patients, child, cyclophosphamide, graft failure, granulocyte colony-stimulating factor, high, neuroblastoma, patient, patients, peripheral-blood stem cells, peripheral-blood stem-cell, stem-cell

Datasets